CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-2652

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients ; volume:13 ; number:4 ; day:8 ; month:11 ; year:2010 ; pages:1-2 ; date:12.2010
Journal of the International AIDS Society / International AIDS Society ; 13, Heft 4 (8.11.2010), 1-2, 12.2010

Creator: Parczewski, M.

Contributor: Leszczyszyn-Pynka, M.
Bander, D.
Urbañska, A.
Kaczmarczyk, M.
Ciechanowicz, S.
Boron-Kaczmarska, A.
SpringerLink (Online service)

DOI: 10.1186/1758-2652-13-S4-P151

URN: urn:nbn:de:1111-2016052059505

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Parczewski, M.
Leszczyszyn-Pynka, M.
Bander, D.
Urbañska, A.
Kaczmarczyk, M.
Ciechanowicz, S.
Boron-Kaczmarska, A.
SpringerLink (Online service)

Other Objects (12)

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Immunological diagnosis of CMV infection in HIV-infected patients

Fasciola hepatica coinfection modifies the morphological and immunological features of Echinococcus granulosus cysts in cattle

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

CCR5 Antagonist and Agonist Binding Site Structures

Reduced CCR5 expression among Uganda HIV controllers

Related objects

Reset password